GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zenotech Laboratories Ltd

Zenotech Labs FY26 Results: Net Loss Rs. 107.21 lakhs, Revenue Rs. 3,956.20 lakhs

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 29 Apr 2026, 04:19 PM IST  ·  BSE ID: 0a5301e4-2a44-4514-9660-ca719b0aa930
View Original BSE Filing (PDF)
💡
In Simple Terms
Zenotech's annual profits turned to losses due to a large Rs. 477 crore tax charge, though operating revenue stayed flat year-on-year.
🤖 AI Summary
  • FY26 revenue Rs. 3,956.20 lakhs, marginally above FY25 Rs. 3,897.57 lakhs — essentially flat growth
  • Net loss FY26 Rs. 107.21 lakhs after deferred tax charge Rs. 477.18 lakhs; FY25 profit Rs. 561.29 lakhs
  • Q4 FY26 operational loss Rs. 98.96 lakhs; full-year EBIT before tax Rs. 418.90 lakhs
  • Total comprehensive income negative Rs. 102.54 lakhs FY26 versus positive Rs. 559.61 lakhs FY25
  • EPS deteriorated to loss Rs. 0.18 per share FY26 from earnings Rs. 0.92 per share FY25
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations FY26
Rs. 3,956.20 lakhs
1.5%
Net profit / (loss) FY26
Rs. (107.21) lakhs
Net profit FY25
Rs. 561.29 lakhs
Deferred tax expense FY26
Rs. 477.18 lakhs
Total tax expense FY26
Rs. 526.11 lakhs
Q4 FY26 operational loss before tax
Rs. (98.96) lakhs
EPS FY26
Rs. (0.18) per share
Cash and equivalents March 31, 2026
Rs. 3,028.93 lakhs
13.9%
Operating cash flow FY26
Rs. 1,020.48 lakhs
6.9%
🏢 How This Affects the Company
📈
Business Impact
Operating revenue marginally increased by 1.5% to Rs. 3,956.20 lakhs in FY26 from Rs. 3,897.57 lakhs in FY25, showing limited organic growth. Q4 saw operational loss of Rs. 98.96 lakhs, indicating softening business momentum in the final quarter.
💰
Financial Impact
Net profit collapsed to loss of Rs. 107.21 lakhs in FY26 from profit of Rs. 561.29 lakhs in FY25, primarily due to deferred tax expense of Rs. 477.18 lakhs. Total tax expense was Rs. 526.11 lakhs in FY26 versus Rs. 507.90 lakhs in FY25, significantly eroding profitability despite stable revenue.
⚙️
Operational Impact
Employee benefit expenses increased to Rs. 1,552.79 lakhs in FY26 from Rs. 1,237.78 lakhs in FY25, representing 25.4% increase in payroll costs. Depreciation and amortization expense Rs. 711.34 lakhs indicates continued capital asset base, with capital expenditure of Rs. 832.23 lakhs in the year.
⚠️
Risk Impact
Deferred tax liability of Rs. 83.14 lakhs created on balance sheet as of March 31, 2026. Loss-making status in FY26 reduces earnings buffer and may constrain dividend capacity and borrowing headroom. The reversal of prior year written back amounts (Rs. 10.27 lakhs FY26 versus Rs. 194.01 lakhs writebacks in FY25) suggests tightening asset quality.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should request detailed management commentary on deferred tax charge nature, Q4 loss drivers, and FY27 recovery plan in next investor call or board communication.
👤
Who Is Affected
All shareholders holding equity; earnings per share deteriorated to loss Rs. 0.18 per share in FY26 from earnings Rs. 0.92 per share in FY25. Dividend capacity severely constrained given loss position.
🔍
Management Signal
The creation of Rs. 83.14 lakhs deferred tax liability and Rs. 477.18 lakhs deferred tax charge suggest management identified material temporary differences in tax positions — indicative of accounting or tax exposure that was previously not recognized.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 results — verify if operational losses reverse and revenue momentum restores above Rs. 1,000 lakhs quarterly
Management commentary on deferred tax charge — confirm nature and one-time versus recurring impact on future tax positions
FY27 guidance or investor update — assess management confidence on cost control and return to profitability trajectory
MEDIUM RISK Swing from Rs. 561.29 crore profit to Rs. 107.21 crore loss in FY26 signals operational stress. Deferred tax liability Rs. 83.14 crore created. Flat revenue growth, rising costs, and negative earnings per share warrant close operational monitoring.
💡 Investor Takeaway
FY26 results show revenue held flat at Rs. 3,956.20 lakhs but profitability inverted — net loss Rs. 107.21 lakhs versus prior year profit Rs. 561.29 lakhs, primarily driven by Rs. 477.18 lakhs deferred tax expense. Operating cash generation remained positive at Rs. 1,020.48 lakhs, preserving liquidity at Rs. 3,028.93 lakhs. Q4 operational loss indicates momentum loss that requires clarification on recovery trajectory.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue stability: FY26 operations revenue Rs. 3,956.20 lakhs maintained near FY25 level despite market headwinds
  • Strong liquidity position: Cash and equivalents Rs. 3,028.93 lakhs as of March 31, 2026, up from Rs. 2,657.51 lakhs prior year

⚠️ Concerns

  • Profitability collapse: Net loss Rs. 107.21 lakhs in FY26 vs. prior year profit Rs. 561.29 lakhs — Rs. 668.50 lakhs swing downward
  • Tax headwind: Deferred tax charge Rs. 477.18 lakhs in FY26 created unexpected liability; prior year saw Rs. 258.57 lakhs deferred tax benefit
📅 Company Track Record
Zenotech Laboratories Limited (CIN: L27100TG1989PLC010122), incorporated 1989, is a Hyderabad-based pharmaceutical/biotech company. No prior public filing context available in system. This is first FY26 audited annual results disclosure on BSE following April 29, 2026 board approval.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.